Generics Industry News Search
 |
|
|
|
|
|
|
|
| |
|
The Medicines Patent Pool (MPP) announced today that two of its generic manufacturing partners are the first companies to apply for prequalification of generic dolutegravir (DTG), a new antiretroviral that the MPP licensed from ViiV Healthcare in 2014....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Momenta and Mylan, today announced that dosing has begun in a Phase 1 study to compare the pharmacokinetics, safety and immunogenicity of M834, a proposed biosimilar of Orencia (Abatacept), to US- and EU-sourced Orencia in normal healthy volunteers. Under the Momenta-Mylan collaboration agreement, Momenta has achieved the milestone necessary to earn a $25 million payment from Mylan....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva today announced approval of generic Tribenzor 1 (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide) tablets in the US and is in the final stages of launch preparation. Teva also recently received approval and launched generic Azor (Amlodipine and Olmesartan Medoxomil) tablets in the US. These products enhance Teva's antihypertensive portfolio....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Coherus today announced that it has received a decision from the Patent Trial and Appeal Board (PTAB) of the US Patent and Trademark Office denying institution of Coherus' petition for Inter Partes Review (IPR) of AbbVie's US9114166 (the "'166 Patent") related to AbbVie's Humira (Adalimumab) formulation....
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your company press releases at GenericsWeb, please email us. |
|
|
News LInks
Pharmaceuticals Search Engine:
A list of major pharma info sources.
Pharmalicencing.com:
News section includes company press releases for a limited number of companies.
Betachem:
Pharma focussed news with archives.
The Scientist:
Science news with daily updates.
Medicines.org.uk:
Regulatory news from EMEA | | |
Home